Monte Rosa Therapeutics (GLUE) Shares Issued (2023 - 2025)
Historic Shares Issued for Monte Rosa Therapeutics (GLUE) over the last 3 years, with Q3 2025 value amounting to $348000.0.
- Monte Rosa Therapeutics' Shares Issued changed N/A to $348000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $362000.0, marking a year-over-year decrease of 9950.4%. This contributed to the annual value of $50.0 million for FY2024, which is 10000.0% up from last year.
- Latest data reveals that Monte Rosa Therapeutics reported Shares Issued of $348000.0 as of Q3 2025.
- Monte Rosa Therapeutics' 5-year Shares Issued high stood at $49.8 million for Q2 2024, and its period low was $14000.0 during Q1 2025.
- Over the past 3 years, Monte Rosa Therapeutics' median Shares Issued value was $622500.0 (recorded in 2023), while the average stood at $9.4 million.
- In the last 5 years, Monte Rosa Therapeutics' Shares Issued surged by 544671.13% in 2024 and then crashed by 9430.89% in 2025.
- Monte Rosa Therapeutics' Shares Issued (Quarter) stood at $23.0 million in 2023, then soared by 116.47% to $49.8 million in 2024, then plummeted by 99.3% to $348000.0 in 2025.
- Its last three reported values are $348000.0 in Q3 2025, $14000.0 for Q1 2025, and $49.8 million during Q2 2024.